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Probiotics are viable microorganisms that can exert
potential benefits to human health. Use of probiotics in
different human diseases and clinical conditions has
gained much attention in the last decades. Several data
exist about the potential benefits of probiotics in pedia-
tric age for the management of some clinical conditions,
with different and sometimes contrasting results. Cur-
rently, strong evidences support the use of probiotics for
treatment of acute infectious diarrhoea and prevention
of antibiotic-associated diarrhoea: bacteria belonging to
the genus of lactobacilli and Saccharomyces boulardii
showed the stronger evidences of benefits in different
clinical trials and meta-analysis [1,2]. For other pediatric
diseases and clinical conditions, evidences of the benefits
of a probiotic supplementation are still not so strong.
The recommendation to administer a probiotics supple-
mentation in preterm, very low birth weight neonates at
risk of developing necrotizing enterocolitis has recently
been criticized by a critical review of the literature that
conclude that well-designed clinical trials are still
needed for suggesting its routinely use in these neonates
[3]. Discussion is still ongoing about the benefits of pro-
biotics in prevention or treatment of other pediatric dis-
eases such as respiratory tract infections, urinary tract
infections, Helicobacter pylori infection or allergic dis-
eases. Clinical trials and meta-analysis about the use of
probiotics in these pediatric clinical conditions have
been published and still continued to be published; how-
ever, study designs are not always comparable and
sometimes inadequate, species of probiotics used in the
studies are different and the benefits demonstrated for
one microorganism are not generalizable to other bac-
teria, results of the studies are still often not unequivo-
cal or contrasting so that strong recommendations are
still lacking. The use of probiotics has been suggested to
be potentially beneficial for the management of gastroin-
testinal functional disorders, such as irritable bowel
syndrome, again, with different results. These clinical con-
ditions are supposed to be the result of a perturbation of
the microbiota balance that leads to dysbiosis, responsible
for the appearance of the characteristic symptoms. How-
ever, pathogenesis of gastrointestinal functional disorders
appear to be much more complex and involve the nervous
system and its bidirectional interactions with the intestine.
Moreover, it has been hypothesized that intestinal micro-
bial composition may itself influence end-points related to
mood state, brain function, and mental outlook. A new
fascinating perspective in studies about microbiota and
probiotics is the characterization of the alterations of
intestinal microbiome and their correlation with abnorm-
alities in the bidirectional gut-brain interactions.
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